Emerald Health Sciences Inc. - 31 Dec 2021 Form 5 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
10%+ Owner
Signature
/s/ Stephen Hall
Issuer symbol
SKYE
Transactions as of
31 Dec 2021
Net transactions value
-$256,667
Form type
5
Filing time
31 Jan 2022, 12:58:22 UTC
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SKYE Common Stock Sale $256,667 -2,566,666 -2.3% $0.1000 111,387,251 07 Aug 2020 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKYE Warrants with Credit Facility of Oct 5, 2018 Award $0 +2,500,000 $0.000000 2,500,000 01 Nov 2018 Common Stock 2,500,000 $0.5000 Direct F1
transaction SKYE Warrants with Credit Facility of Oct 5, 2018 Award $0 +2,500,000 $0.000000 2,500,000 01 Feb 2019 Common Stock 2,500,000 $0.5000 Direct F1
transaction SKYE Warrants with Credit Facility of Oct 5, 2018 Award $0 +2,500,000 $0.000000 2,500,000 29 Mar 2019 Common Stock 2,500,000 $0.5000 Direct F1
transaction SKYE Multi Draw Credit Facility - T2 Award $0 +38,822 $0.000000 38,822 01 Feb 2019 Common Stock 38,822 $0.4000 Direct F1, F2
transaction SKYE Multi Draw Credit Facility - T3 Award $0 +5,354,861 $0.000000 5,354,861 29 Mar 2019 Common Stock 5,354,861 $0.4000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions were previously reported on various prior Form 4 filings; however, the entries were erroneously reported as non-derivative transactions in Common Stock and the resulting reported total ownership included the misclassified securities. The entry of these transactions is to correct this error and reflect the actual securities held by the Reporting Person.
F2 The Multi Draw Credit Facility tranches have the option to convert into Common Stock upon maturity of the facilities.